Carregant...
Combining endocannabinoids with retigabine for enhanced M-channel effect and improved K(V)7 subtype selectivity
Retigabine is unique among anticonvulsant drugs by targeting the neuronal M-channel, which is composed of K(V)7.2/K(V)7.3 and contributes to the negative neuronal resting membrane potential. Unfortunately, retigabine causes adverse effects, which limits its clinical use. Adverse effects may be reduc...
Guardat en:
| Publicat a: | J Gen Physiol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Rockefeller University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7398146/ https://ncbi.nlm.nih.gov/pubmed/32365171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1085/jgp.202012576 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|